High Paying US Jobs, Economic Empowerment

&

Revitalization of States through Federal Power

"Critical Field" Technology Innovation 

&

Maximized Profits on R&D and Investments

Prevention of Biochemical and Nuclear Proliferation

&

Homeland Security Technologies

National Council on Innovative Technology Commercialization

International Council on Innovative Technology Commercialization

Critical Field Innovations

Commercialization Programs

About Us

ACI Liver Disease Research Center

The state of the liver is crucial to the health of the whole human body. Despite dramatic advances achieved in the treatment of hepatic diseases, the prevalence of viral hepatitides -(Inflammation of the liver, caused by infectious or toxic agents and characterized by yellowish discoloration of the whites of the eyes, skin, and mucous membranes, fever, liver enlargement, and sever abdominal pain) - became prohibitively alarming.

Today, more then one third of the Earth’s population is infected with hepatitis B and the frequency of occurrence of hepatitis C poses a similarly urgent problem. World death rates related to hepatic diseases are expected to double. Hepatitides and cirrhosis of the liver - (A chronic disease of the liver characterized by the replacement of normal tissue with fibrous tissue and the loss of functional liver cells that can result from alcohol abuse, nutritional deprivation, or infection especially by the hepatitis virus) - rank fifth as causes of death  in the United States, and fourth in Europe. The search for a cure and new methods of treatment of hepatic diseases is of great importance.